Prolific Labs has achieved this leadership position because of various factors such as backward integration to basic starting materials, dedicated production blocks with large batch sizes and significant capacity creation ahead of time. Prolific Labs continues to be committed to providing complementary role to the customer by being dedicated to API manufacturing.
Prolific Labs is engaged in Custom Synthesis of APIs and Intermediates for global innovator companies with a vast portfolio of products across diverse therapeutic areas. Prolific Labs is competent in handling high energetic reactions with high potency to address unmet requirements of the Big Pharma customers. Both the manufacturing units have undergone several EHS, Quality and Sustainability audits by several Big Pharma..
Prolific Labs Nutraceutical Facility at its Unit II manufacturing site is an integrated facility for production of active ingredient and finished forms of Carotenoids. The facility includes a full-fledged R&D, Application Testing and Support Facility. Prolific Labs is currently supplying most of the carotenoids to all the major food, dietary supplement and feed manufacturers around the world.
The R&D team at Prolific Labs is engaged in developing non-infringing processes attaining commercially viable price throughout the lifecycle of the product, infiltrating continuous process improvements
Prolific Labs currently operates two manufacturing locations that are compliant with global regulatory standards and capable of producing annual requirements ranging from 10’s of kilos to 1000’s of tons.
Prolific Labs complies with cGMP guidelines for both the manufacturing units, having been inspected numerous times by FDA, EU GMP , HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities.
Prolific Labs has grown to become one of India’s most respected pharmaceutical companies. It is committed to delivering better health through superior products. By combining strategic research and in-depth industry knowledge, Prolific Labs aims to transform itself into a global pharmaceutical drug company with an increasing focus on cutting-edge research and developed markets. With formulations forming the core of Prolific Labs business, the company also manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has several pharma products that address relevant and growing therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management among others. Promoted by a pioneer of the Indian pharmaceuticals business. It is committed to delivering better health through superior products.